vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and ASGN Inc (ASGN). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $970.0M, roughly 1.3× ASGN Inc). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs 0.6%, a 0.4% gap on every dollar of revenue. On growth, ASGN Inc posted the faster year-over-year revenue change (-3.0% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -3.2%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.

ALHC vs ASGN — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.3× larger
ALHC
$1.2B
$970.0M
ASGN
Growing faster (revenue YoY)
ASGN
ASGN
+71.7% gap
ASGN
-3.0%
-74.7%
ALHC
Higher net margin
ALHC
ALHC
0.4% more per $
ALHC
0.9%
0.6%
ASGN
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
34.6%
-3.2%
ASGN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALHC
ALHC
ASGN
ASGN
Revenue
$1.2B
$970.0M
Net Profit
$11.4M
$5.5M
Gross Margin
27.5%
Operating Margin
2.9%
Net Margin
0.9%
0.6%
Revenue YoY
-74.7%
-3.0%
Net Profit YoY
-73.7%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
ASGN
ASGN
Q1 26
$1.2B
$970.0M
Q4 25
$1.0B
$980.1M
Q3 25
$993.7M
$1.0B
Q2 25
$1.0B
$1.0B
Q1 25
$926.9M
$968.3M
Q4 24
$701.2M
$985.0M
Q3 24
$692.4M
$1.0B
Q2 24
$681.3M
$1.0B
Net Profit
ALHC
ALHC
ASGN
ASGN
Q1 26
$11.4M
$5.5M
Q4 25
$-11.0M
$25.2M
Q3 25
$3.7M
$38.1M
Q2 25
$15.7M
$29.3M
Q1 25
$-9.1M
$20.9M
Q4 24
$-31.1M
$42.4M
Q3 24
$-26.4M
$47.5M
Q2 24
$-24.0M
$47.2M
Gross Margin
ALHC
ALHC
ASGN
ASGN
Q1 26
27.5%
Q4 25
28.9%
Q3 25
29.4%
Q2 25
28.7%
Q1 25
28.4%
Q4 24
29.0%
Q3 24
29.1%
Q2 24
29.1%
Operating Margin
ALHC
ALHC
ASGN
ASGN
Q1 26
2.9%
Q4 25
-1.0%
5.7%
Q3 25
0.8%
6.7%
Q2 25
2.2%
5.8%
Q1 25
-0.6%
4.8%
Q4 24
-3.2%
7.5%
Q3 24
-2.8%
7.7%
Q2 24
-2.7%
7.8%
Net Margin
ALHC
ALHC
ASGN
ASGN
Q1 26
0.9%
0.6%
Q4 25
-1.1%
2.6%
Q3 25
0.4%
3.8%
Q2 25
1.5%
2.9%
Q1 25
-1.0%
2.2%
Q4 24
-4.4%
4.3%
Q3 24
-3.8%
4.6%
Q2 24
-3.5%
4.6%
EPS (diluted)
ALHC
ALHC
ASGN
ASGN
Q1 26
$0.13
Q4 25
$-0.04
$0.58
Q3 25
$0.02
$0.87
Q2 25
$0.07
$0.67
Q1 25
$-0.05
$0.48
Q4 24
$-0.15
$0.94
Q3 24
$-0.14
$1.06
Q2 24
$-0.13
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
ASGN
ASGN
Cash + ST InvestmentsLiquidity on hand
$705.6M
$143.6M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$206.9M
$1.8B
Total Assets
$1.3B
$4.0B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
ASGN
ASGN
Q1 26
$705.6M
$143.6M
Q4 25
$604.2M
$161.2M
Q3 25
$644.1M
Q2 25
$503.8M
Q1 25
$479.5M
Q4 24
$470.6M
$205.2M
Q3 24
$381.0M
Q2 24
$363.7M
Total Debt
ALHC
ALHC
ASGN
ASGN
Q1 26
$1.5B
Q4 25
$323.2M
$1.2B
Q3 25
$322.7M
$1.2B
Q2 25
$322.3M
$1.2B
Q1 25
$321.9M
$1.3B
Q4 24
$321.4M
$1.0B
Q3 24
$212.0M
$1.0B
Q2 24
$211.7M
$1.0B
Stockholders' Equity
ALHC
ALHC
ASGN
ASGN
Q1 26
$206.9M
$1.8B
Q4 25
$179.3M
$1.8B
Q3 25
$161.9M
$1.8B
Q2 25
$141.0M
$1.8B
Q1 25
$108.1M
$1.8B
Q4 24
$99.9M
$1.8B
Q3 24
$114.5M
$1.8B
Q2 24
$123.7M
$1.8B
Total Assets
ALHC
ALHC
ASGN
ASGN
Q1 26
$1.3B
$4.0B
Q4 25
$1.1B
$3.7B
Q3 25
$1.1B
$3.7B
Q2 25
$1.0B
$3.7B
Q1 25
$895.6M
$3.7B
Q4 24
$782.1M
$3.4B
Q3 24
$692.3M
$3.4B
Q2 24
$716.3M
$3.5B
Debt / Equity
ALHC
ALHC
ASGN
ASGN
Q1 26
0.82×
Q4 25
1.80×
0.65×
Q3 25
1.99×
0.64×
Q2 25
2.29×
0.66×
Q1 25
2.98×
0.72×
Q4 24
3.22×
0.58×
Q3 24
1.85×
0.58×
Q2 24
1.71×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
ASGN
ASGN
Operating Cash FlowLast quarter
$128.7M
Free Cash FlowOCF − Capex
$9.1M
FCF MarginFCF / Revenue
0.9%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters
$290.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
ASGN
ASGN
Q1 26
$128.7M
Q4 25
$-50.4M
$102.3M
Q3 25
$144.6M
$83.9M
Q2 25
$29.1M
$124.9M
Q1 25
$16.6M
$16.8M
Q4 24
$-8.7M
$100.2M
Q3 24
$26.2M
$135.8M
Q2 24
$23.5M
$90.7M
Free Cash Flow
ALHC
ALHC
ASGN
ASGN
Q1 26
$9.1M
Q4 25
$-55.4M
$93.7M
Q3 25
$139.1M
$72.0M
Q2 25
$21.1M
$115.8M
Q1 25
$8.4M
$6.6M
Q4 24
$-18.0M
$88.9M
Q3 24
$16.9M
$127.9M
Q2 24
$11.8M
$85.4M
FCF Margin
ALHC
ALHC
ASGN
ASGN
Q1 26
0.9%
Q4 25
-5.5%
9.6%
Q3 25
14.0%
7.1%
Q2 25
2.1%
11.3%
Q1 25
0.9%
0.7%
Q4 24
-2.6%
9.0%
Q3 24
2.4%
12.4%
Q2 24
1.7%
8.3%
Capex Intensity
ALHC
ALHC
ASGN
ASGN
Q1 26
1.0%
Q4 25
0.5%
0.9%
Q3 25
0.6%
1.2%
Q2 25
0.8%
0.9%
Q1 25
0.9%
1.1%
Q4 24
1.3%
1.1%
Q3 24
1.3%
0.8%
Q2 24
1.7%
0.5%
Cash Conversion
ALHC
ALHC
ASGN
ASGN
Q1 26
11.27×
Q4 25
4.06×
Q3 25
38.77×
2.20×
Q2 25
1.86×
4.26×
Q1 25
0.80×
Q4 24
2.36×
Q3 24
2.86×
Q2 24
1.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons